QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
QQQ   389.91 (+0.72%)
AAPL   163.76 (-0.61%)
MSFT   329.49 (-0.18%)
FB   310.39 (-0.07%)
GOOGL   2,859.32 (+1.36%)
AMZN   3,437.36 (-0.18%)
TSLA   1,084.60 (-0.95%)
NVDA   321.26 (+2.20%)
BABA   122.00 (-0.40%)
NIO   36.20 (-5.51%)
CGC   10.36 (+4.23%)
AMD   150.68 (+1.05%)
GE   95.23 (+2.40%)
MU   82.88 (-2.67%)
T   23.05 (+3.69%)
F   19.87 (+1.48%)
DIS   147.20 (+3.55%)
PFE   53.04 (-3.00%)
AMC   30.28 (+5.99%)
ACB   6.14 (+2.16%)
BA   202.38 (+7.54%)
NASDAQ:CME

CME Group Stock Forecast, Price & News

$226.55
+6.54 (+2.97%)
(As of 12/2/2021 04:00 PM ET)
Add
Compare
Today's Range
$220.46
$228.29
50-Day Range
$193.38
$228.94
52-Week Range
$177.15
$230.90
Volume
1.37 million shs
Average Volume
1.42 million shs
Market Capitalization
$81.42 billion
P/E Ratio
33.41
Dividend Yield
1.64%
Beta
0.47
30 days | 90 days | 365 days | Advanced Chart
Receive CME News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.


CME Group logo

About CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
Specialized Finance
Sector
Finance
Current Symbol
NASDAQ:CME
CUSIP
12572Q10
Employees
4,370
Year Founded
1848

Sales & Book Value

Annual Sales
$4.88 billion
Cash Flow
$8.18 per share
Book Value
$73.52 per share

Profitability

Net Income
$2.11 billion
Pretax Margin
67.00%

Debt

Price-To-Earnings

Miscellaneous

Free Float
358,321,000
Market Cap
$81.42 billion
Optionable
Optionable

Company Calendar

Ex-Dividend
9/09/2021
Dividend Payable
9/27/2021
Last Earnings
10/27/2021
Today
12/02/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/09/2022

Social Links


MarketRank

Overall MarketRank

3.04 out of 5 stars

Finance Sector

95th out of 1,340 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

2nd out of 14 stocks

Analyst Opinion: 2.2Community Rank: 4.3Dividend Strength: 4.2Insider Behavior: 3.3Valuation: 1.3 5 -4 -3 -2 -1 -












CME Group (NASDAQ:CME) Frequently Asked Questions

Is CME Group a buy right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last year. There are currently 1 sell rating, 7 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CME Group stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View analyst ratings for CME Group
or view top-rated stocks.

How has CME Group's stock been impacted by COVID-19?

CME Group's stock was trading at $194.6750 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, CME stock has increased by 16.4% and is now trading at $226.55.
View which stocks have been most impacted by COVID-19
.

When is CME Group's next earnings date?

CME Group is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022.
View our earnings forecast for CME Group
.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) released its quarterly earnings data on Wednesday, October, 27th. The financial services provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.05. The financial services provider had revenue of $1.11 billion for the quarter, compared to analyst estimates of $1.15 billion. CME Group had a trailing twelve-month return on equity of 8.60% and a net margin of 52.47%. The business's revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the prior year, the business earned $1.38 EPS.
View CME Group's earnings history
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group declared a quarterly dividend on Thursday, November 4th. Stockholders of record on Friday, December 10th will be given a dividend of $0.90 per share on Tuesday, December 28th. This represents a $3.60 annualized dividend and a yield of 1.59%. The ex-dividend date is Thursday, December 9th.
View CME Group's dividend history
.

Is CME Group a good dividend stock?

CME Group pays an annual dividend of $3.60 per share and currently has a dividend yield of 1.64%. CME Group has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of CME Group is 53.10%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME Group will have a dividend payout ratio of 50.21% next year. This indicates that CME Group will be able to sustain or increase its dividend.
View CME Group's dividend history.

What price target have analysts set for CME?

15 equities research analysts have issued 12-month target prices for CME Group's shares. Their forecasts range from $196.00 to $235.00. On average, they expect CME Group's share price to reach $218.08 in the next twelve months. This suggests that the stock has a possible downside of 3.7%.
View analysts' price targets for CME Group
or view top-rated stocks among Wall Street analysts.

Who are CME Group's key executives?

CME Group's management team includes the following people:

What is Terry Duffy's approval rating as CME Group's CEO?

144 employees have rated CME Group CEO Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among CME Group's employees.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

What is CME Group's stock symbol?

CME Group trades on the NASDAQ under the ticker symbol "CME."

Who are CME Group's major shareholders?

CME Group's stock is owned by a number of institutional and retail investors. Top institutional investors include Capital World Investors (9.36%), BlackRock Inc. (7.11%), Edgewood Management LLC (2.68%), Capital Research Global Investors (2.37%), Parnassus Investments LLC (1.97%) and Parnassus Investments LLC (1.96%). Company insiders that own CME Group stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Terrence A Duffy, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends for CME Group
.

Which major investors are selling CME Group stock?

CME stock was sold by a variety of institutional investors in the last quarter, including Mawer Investment Management Ltd., Wellington Management Group LLP, Sepio Capital LP, Capital Research Global Investors, Caisse DE Depot ET Placement DU Quebec, Capital World Investors, Alliancebernstein L.P., and DekaBank Deutsche Girozentrale. Company insiders that have sold CME Group company stock in the last year include Bryan T Durkin, Dennis Suskind, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Sean Tully, Terrence A Duffy, and Timothy S Bitsberger.
View insider buying and selling activity for CME Group
or view top insider-selling stocks.

Which major investors are buying CME Group stock?

CME stock was bought by a variety of institutional investors in the last quarter, including Parnassus Investments LLC, Parnassus Investments LLC, BlackRock Inc., Arrowstreet Capital Limited Partnership, Healthcare of Ontario Pension Plan Trust Fund, Troy Asset Management Ltd, Renaissance Technologies LLC, and CI Investments Inc.. Company insiders that have bought CME Group stock in the last two years include Terrence A Duffy, and William R Shepard.
View insider buying and selling activity for CME Group
or or view top insider-buying stocks.

How do I buy shares of CME Group?

Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CME Group's stock price today?

One share of CME stock can currently be purchased for approximately $226.55.

How much money does CME Group make?

CME Group has a market capitalization of $81.42 billion and generates $4.88 billion in revenue each year. The financial services provider earns $2.11 billion in net income (profit) each year or $6.78 on an earnings per share basis.

How many employees does CME Group have?

CME Group employs 4,370 workers across the globe.

When was CME Group founded?

CME Group was founded in 1848.

What is CME Group's official website?

The official website for CME Group is www.cmegroup.com.

Where are CME Group's headquarters?

CME Group is headquartered at 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606.

How can I contact CME Group?

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at (312) 930-1000, via email at [email protected], or via fax at 312-466-4410.


This page was last updated on 12/2/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.